TELA BIO INC (TELA)
US8723811084 - Common Stock
TELA gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 187 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of TELA have multiple concerns. TELA is valued quite expensive, but it does show an excellent growth.
1. Profitability
1.1 Basic Checks
In the past year TELA has reported negative net income.
TELA had a negative operating cash flow in the past year.
In the past 5 years TELA always reported negative net income.
In the past 5 years TELA always reported negative operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -78.32%, TELA is doing worse than 79.03% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -78.32% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-59.43%
ROA(5y)-51.21%
ROE(3y)-240.76%
ROE(5y)-175.72%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
The Gross Margin of TELA (68.31%) is better than 76.88% of its industry peers.
TELA's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for TELA so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.31% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.63%
GM growth 5Y14.06%
2. Health
2.1 Basic Checks
TELA does not have a ROIC to compare to the WACC, probably because it is not profitable.
TELA has more shares outstanding than it did 1 year ago.
The number of shares outstanding for TELA has been increased compared to 5 years ago.
Compared to 1 year ago, TELA has an improved debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -9.00, we must say that TELA is in the distress zone and has some risk of bankruptcy.
TELA's Altman-Z score of -9.00 is on the low side compared to the rest of the industry. TELA is outperformed by 79.03% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -9 |
ROIC/WACCN/A
WACC9.98%
2.3 Liquidity
A Current Ratio of 2.62 indicates that TELA has no problem at all paying its short term obligations.
TELA has a Current ratio (2.62) which is comparable to the rest of the industry.
A Quick Ratio of 1.81 indicates that TELA should not have too much problems paying its short term obligations.
The Quick ratio of TELA (1.81) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.62 | ||
| Quick Ratio | 1.81 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an nice 17.96% over the past year.
Looking at the last year, TELA shows a very strong growth in Revenue. The Revenue has grown by 29.36%.
The Revenue has been growing by 47.86% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)17.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.67%
Revenue 1Y (TTM)29.36%
Revenue growth 3Y47.51%
Revenue growth 5Y47.86%
Sales Q2Q%25.94%
3.2 Future
The Earnings Per Share is expected to grow by 19.13% on average over the next years. This is quite good.
The Revenue is expected to grow by 26.66% on average over the next years. This is a very strong growth
EPS Next Y33.46%
EPS Next 2Y29.7%
EPS Next 3Y23.37%
EPS Next 5Y19.13%
Revenue Next Year29.1%
Revenue Next 2Y27.29%
Revenue Next 3Y26.31%
Revenue Next 5Y26.66%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for TELA. In the last year negative earnings were reported.
Also next year TELA is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
TELA's earnings are expected to grow with 23.37% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y29.7%
EPS Next 3Y23.37%
5. Dividend
5.1 Amount
TELA does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
TELA BIO INC
NASDAQ:TELA (1/3/2025, 8:05:24 PM)
After market: 2.91 0 (0%)2.91
+0.03 (+1.04%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners72.25%
Inst Owner Change-2.44%
Ins Owners7.13%
Ins Owner Change3.66%
Market Cap114.62M
Analysts83.64
Price Target9.38 (222.34%)
Short Float %0.97%
Short Ratio1.16
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-3.88%
Min EPS beat(2)-5.93%
Max EPS beat(2)-1.82%
EPS beat(4)1
Avg EPS beat(4)6.95%
Min EPS beat(4)-19.5%
Max EPS beat(4)55.05%
EPS beat(8)4
Avg EPS beat(8)6.21%
EPS beat(12)4
Avg EPS beat(12)-1.13%
EPS beat(16)4
Avg EPS beat(16)-3.11%
Revenue beat(2)0
Avg Revenue beat(2)-7.98%
Min Revenue beat(2)-14.54%
Max Revenue beat(2)-1.41%
Revenue beat(4)1
Avg Revenue beat(4)-3.64%
Min Revenue beat(4)-14.54%
Max Revenue beat(4)1.66%
Revenue beat(8)1
Avg Revenue beat(8)-5.16%
Revenue beat(12)5
Avg Revenue beat(12)-2.95%
Revenue beat(16)7
Avg Revenue beat(16)-1.07%
PT rev (1m)0%
PT rev (3m)-14.81%
EPS NQ rev (1m)0%
EPS NQ rev (3m)41.06%
EPS NY rev (1m)0%
EPS NY rev (3m)6.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)9.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.42%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 1.67 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-1.69
EYN/A
EPS(NY)-0.66
Fwd EYN/A
FCF(TTM)-1.17
FCFYN/A
OCF(TTM)-1.15
OCFYN/A
SpS1.74
BVpS-0.16
TBVpS-0.21
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -78.32% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 68.31% | ||
| FCFM | N/A |
ROA(3y)-59.43%
ROA(5y)-51.21%
ROE(3y)-240.76%
ROE(5y)-175.72%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.63%
GM growth 5Y14.06%
F-Score1
Asset Turnover1.29
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 102.43% | ||
| Cap/Sales | 1.35% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 2.62 | ||
| Quick Ratio | 1.81 | ||
| Altman-Z | -9 |
F-Score1
WACC9.98%
ROIC/WACCN/A
Cap/Depr(3y)117.65%
Cap/Depr(5y)170.23%
Cap/Sales(3y)2.57%
Cap/Sales(5y)5.22%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)17.96%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.67%
EPS Next Y33.46%
EPS Next 2Y29.7%
EPS Next 3Y23.37%
EPS Next 5Y19.13%
Revenue 1Y (TTM)29.36%
Revenue growth 3Y47.51%
Revenue growth 5Y47.86%
Sales Q2Q%25.94%
Revenue Next Year29.1%
Revenue Next 2Y27.29%
Revenue Next 3Y26.31%
Revenue Next 5Y26.66%
EBIT growth 1Y-10.65%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year24.11%
EBIT Next 3Y25.65%
EBIT Next 5Y26.21%
FCF growth 1Y-13.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-14.61%
OCF growth 3YN/A
OCF growth 5YN/A